Key facts
- Kapiva’s last known valuation is $42.8M (Oct 2021).
- It has raised $94.5M; the latest was Later Stage VC ($60.0M) in Sep 2025.
- Notable investors include Alteria Capital, OrbiMed, 3one4 Capital, Vertex Ventures Southeast Asia & India, Vertex Growth — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Kapiva
- ·The full record, as it builds
Funding rounds
No funding rounds for Kapiva are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kapiva
Producer of ayurvedic nutrition products intended to improve the health and lifestyle of consumers. The company provides a wide range of ghee, honey, juices, teas, oils, plant protein powders, and other similar products, enabling consumers to access natural, pure, and authentic nutritional products.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Bengaluru, India
- Founded
- 2015
- Employees
- 393
- Website
- kapiva.in/
- Ownership
- Privately Held (backing)
Kapiva doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kapiva shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kapiva in its N-PORT filings yet. We sweep new filings monthly.